132 related articles for article (PubMed ID: 1998952)
21. Changes in diacylglycerol and membrane associated protein kinase C activity reflect the growth status of xenografted human mammary carcinoma treated with 8-Cl-cAMP.
Parandoosh Z; Rubalcava B; Finch RA; Robins RK; Avery TL
Cancer Lett; 1990 Mar; 49(3):195-200. PubMed ID: 2317779
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of radiosensitivity by combined ceramide and dimethylsphingosine treatment in lung cancer cells.
Park HW; Song JY; Kim KS; Han Y; Kim CW; Yi SY; Yun YS
Exp Mol Med; 2004 Oct; 36(5):411-9. PubMed ID: 15557813
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco AR; Tortora G
Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932
[TBL] [Abstract][Full Text] [Related]
24. The signal modulator protein 14-3-3 is a target of sphingosine- or N,N-dimethylsphingosine-dependent kinase in 3T3(A31) cells.
Megidish T; White T; Takio K; Titani K; Igarashi Y; Hakomori S
Biochem Biophys Res Commun; 1995 Nov; 216(3):739-47. PubMed ID: 7488188
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.
Akinaga S; Gomi K; Morimoto M; Tamaoki T; Okabe M
Cancer Res; 1991 Sep; 51(18):4888-92. PubMed ID: 1893379
[TBL] [Abstract][Full Text] [Related]
26. N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets.
Yatomi Y; Ruan F; Megidish T; Toyokuni T; Hakomori S; Igarashi Y
Biochemistry; 1996 Jan; 35(2):626-33. PubMed ID: 8555236
[TBL] [Abstract][Full Text] [Related]
27. [Sphingosine kinase 1 enhances the proliferation and invasion of human colon cancer LoVo cells through up-regulating FAK pathway and the expression of ICAM-1 and VCAM-1].
Liu SQ; Su YJ; Huang JA; Qin MB; Tang GD
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):331-6. PubMed ID: 24054007
[TBL] [Abstract][Full Text] [Related]
28. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
29. N,N-Dimethyl-D-erythro-sphingosine inhibits store-operated Ca2+ entry in U937 monocytes.
Jo JY; Kim HL; Lee YK; Tomura H; Bae YS; Okajima F; Im DS
J Pharmacol Sci; 2008 Jul; 107(3):303-7. PubMed ID: 18635921
[TBL] [Abstract][Full Text] [Related]
30. N,N-dimethylsphingosine attenuates myocardial ischemia-reperfusion injury by recruiting regulatory T cells through PI3K/Akt pathway in mice.
Fang J; Hu F; Ke D; Yan Y; Liao Z; Yuan X; Wu L; Jiang Q; Chen L
Basic Res Cardiol; 2016 May; 111(3):32. PubMed ID: 27048490
[TBL] [Abstract][Full Text] [Related]
31. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice.
Shukla S; Mishra A; Fu P; MacLennan GT; Resnick MI; Gupta S
FASEB J; 2005 Dec; 19(14):2042-4. PubMed ID: 16230333
[TBL] [Abstract][Full Text] [Related]
34. Site-selective 8-chloro-cyclic adenosine 3',5'-monophosphate as a biologic modulator of cancer: restoration of normal control mechanisms.
Cho-Chung YS
J Natl Cancer Inst; 1989 Jul; 81(13):982-7. PubMed ID: 2659804
[No Abstract] [Full Text] [Related]
35. Inhibition of MAP kinase by sphingosine and its methylated derivative, N,N-dimethylsphingosine.
Sakakura C; Sweeney E; Shirahama T; Ruan F; Solca F; Kohno M; Hakomori S; Fischer E; Igarashi Y
Int J Oncol; 1997 Jul; 11(1):31-9. PubMed ID: 21528177
[TBL] [Abstract][Full Text] [Related]
36. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
[TBL] [Abstract][Full Text] [Related]
37. Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts.
Vincent PW; Bridges AJ; Dykes DJ; Fry DW; Leopold WR; Patmore SJ; Roberts BJ; Rose S; Sherwood V; Zhou H; Elliott WL
Cancer Chemother Pharmacol; 2000; 45(3):231-8. PubMed ID: 10663641
[TBL] [Abstract][Full Text] [Related]
38. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L
Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925
[TBL] [Abstract][Full Text] [Related]
39. Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412.
Zaugg K; Rocha S; Resch H; Hegyi I; Oehler C; Glanzmann C; Fabbro D; Bodis S; Pruschy M
Cancer Res; 2001 Jan; 61(2):732-8. PubMed ID: 11212276
[TBL] [Abstract][Full Text] [Related]
40. Multiple actions of dimethylsphingosine in 1321N1 astrocytes.
Lee YK; Kim HL; Kim YL; Im DS
Mol Cells; 2007 Feb; 23(1):11-6. PubMed ID: 17464206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
